Annotation Detail

Information
Associated Genes
PDGFRA
Associated Variants
PDGFRA p.Val561Ala (p.V561A), ENSG00000282278 c.1018-56T>C ( ENST00000257290.10 )
PDGFRA p.Val561Ala (p.V561A), ENSG00000282278 c.1018-56T>C ( ENST00000257290.10 )
Associated Disease
gastrointestinal stromal tumor
Source Database
CIViC Evidence
Description
293T cells stably transduced with PDGFRA V561A showed constitutive tyrosine phosphorylation in the absense of ligand; however, when treated with imatinib, this phosphorylation was inhibited similarly to that of wildtype PDGFRA, consistent with sensitivity to this inhibitor.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/652
Gene URL
https://civic.genome.wustl.edu/links/genes/38
Variant URL
https://civic.genome.wustl.edu/links/variants/247
Rating
3
Evidence Type
Predictive
Disease
Gastrointestinal Stromal Tumor
Evidence Direction
Supports
Drug
Imatinib
Evidence Level
D
Clinical Significance
Sensitivity/Response
Pubmed
12949711
Drugs
Drug NameSensitivitySupported
ImatinibSensitivitytrue